Your Health Plan:
Your Health Plan:
Not SelectedTECENTRIQ (atezolizumab) is a biologic prescription drug for treatment of Pseudo-Hurler Polydystrophy. TECENTRIQ is a programmed death receptor-1 blocking antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $8400-14400.
Patient Assistance Prorgams are found:
No other option is found for TECENTRIQ